Home > Historical Performance > Historical Transaction Report

Transaction Details

Company: ViroPharma
Yahoo Beta:1.37

Company Description:  ViroPharma, Inc. is a biotechnology company the develops and produces drugs for serious genetic diseases.

Purchase Date:29 Feb 2012 Sale Date:12 Apr 2012
Purchase Price:$32.42 Sale Price:$22.15
  --Split Adjusted:$32.42  --Split Adjusted:$22.15
Shares Purchased:150 Shares Sold:150
  --Split Adjusted:150  --Split Adjusted:150
Transaction Fee:$8.95 Transaction Fee:$9.02
Price Range (6 Months Prior):    Price Range (6 Months After):    
High$32.33 High$0.00
Date17 Feb 2012 Date01 Jan 1996
Low$17.50 Low$0.00
Date22 Sep 2011 Date01 Jan 1996
S&P (Purchase Date):$1,365.68 S&P (Sale Date):$1,386.02

Timing:  We bought at the six month high.

Reason:  The FDA allowed a competitor to introduce a generic version of VPHM's largest selling drug, reducing the company's value. We don't see a near-term recovery and are looking for better alternatives.

S&P Gain: 1.49 % Annualized Gain: 13.72%
Stock Gain: -31.68 % Annualized Gain: -96.35%

Net Holding Return ($): $-1,558.47
Net Holding Return (%): -31.99 %